Cargando…

Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload

microRNAs (miRNAs or miRs) are essential in cardiac hypertrophy and in the development of heart failure. In the present study, we aimed to determine whether the restoration of miRNA-455 (miR-455) gene expression in vivo aggravates hypertrophy, but protects against adverse cardiac remodeling induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	WU, CHUNTAO, DONG, SHIMIN, LI, YONGJUN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356433/ https://www.ncbi.nlm.nih.gov/pubmed/25695617 http://dx.doi.org/10.3892/ijmm.2015.2105

Ejemplares similares

Engineered Circular RNA Sponges Act as miRNA Inhibitors to Attenuate Pressure Overload-Induced Cardiac Hypertrophy
por: Lavenniah, Annadoray, et al.
Publicado: (2020)

Effective Delivery of Hypertrophic miRNA Inhibitor by Cholesterol‐Containing Nanocarriers for Preventing Pressure Overload Induced Cardiac Hypertrophy
por: Zhi, Ying, et al.
Publicado: (2019)

The function of miRNA in cardiac hypertrophy
por: Wang, Jian, et al.
Publicado: (2012)

MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload
por: Ji, Yue, et al.
Publicado: (2018)

Microtubule Stabilization in Pressure Overload Cardiac Hypertrophy
por: Sato, Hiroshi, et al.
Publicado: (1997)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017)

miR-21 upregulation exacerbates pressure overload-induced cardiac hypertrophy in aged hearts
por: Chang, Wei-Ting, et al.
Publicado: (2022)

IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Dai, Jia, et al.
Publicado: (2013)

Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling
por: Liu, Xin, et al.
Publicado: (2021)

Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy
por: Zhen, Changlin, et al.
Publicado: (2023)

Comprehensive analysis of RNA m6A methylation in pressure overload-induced cardiac hypertrophy
por: Li, Weidong, et al.
Publicado: (2022)

Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats
por: Hao, Jia, et al.
Publicado: (2007)

Protective Roles of Interferon‐γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload
por: Kimura, Akihiko, et al.
Publicado: (2018)

Peroxiredoxin-5 Knockdown Accelerates Pressure Overload-Induced Cardiac Hypertrophy in Mice
por: Hu, Chengyun, et al.
Publicado: (2022)

Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy
por: Yang, Chongzhe, et al.
Publicado: (2022)

Intermedin Suppresses Pressure Overload Cardiac Hypertrophy through Activation of Autophagy
por: Chen, HuaLi, et al.
Publicado: (2013)

Effects of Estrogen, an ERα Agonist and Raloxifene on Pressure Overload Induced Cardiac Hypertrophy
por: Westphal, Christina, et al.
Publicado: (2012)

Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling
por: Karakikes, Ioannis, et al.
Publicado: (2013)

TANK Promotes Pressure Overload Induced Cardiac Hypertrophy via Activating AKT Signaling Pathway
por: Pang, Yanan, et al.
Publicado: (2021)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
por: Guo, Xinji, et al.
Publicado: (2020)

Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy
por: Ma, Sai, et al.
Publicado: (2021)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
Publicado: (2022)

Electrophysiological characteristics of pressure overload-induced cardiac hypertrophy and its influence on ventricular arrhythmias
por: Chen, Xiaowei, et al.
Publicado: (2017)

Loss of Akap1 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
por: Schiattarella, Gabriele G., et al.
Publicado: (2018)

TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice
por: Wang, Zhen, et al.
Publicado: (2018)

Thymoquinone ameliorates pressure overload‐induced cardiac hypertrophy by activating the AMPK signalling pathway
por: Chen, Heng, et al.
Publicado: (2021)

Activation of transient receptor potential vanilloid 4 is involved in pressure overload-induced cardiac hypertrophy
por: Zou, Yan, et al.
Publicado: (2022)

Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II
por: Li, Shujun, et al.
Publicado: (2021)

The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis
por: Tojima, Mikuto, et al.
Publicado: (2021)

Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
por: Nordén, Einar Sjaastad, et al.
Publicado: (2021)

Diet-induced obesity promotes altered remodeling and exacerbated cardiac hypertrophy following pressure overload
por: Holzem, Katherine M, et al.
Publicado: (2015)

Salubrinal Alleviates Pressure Overload-Induced Cardiac Hypertrophy by Inhibiting Endoplasmic Reticulum Stress Pathway
por: Rani, Shilpa, et al.
Publicado: (2017)

The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice
por: Omede, Ameh, et al.
Publicado: (2016)

Soluble adenylyl cyclase: A novel player in cardiac hypertrophy induced by isoprenaline or pressure overload
por: Schirmer, Ilona, et al.
Publicado: (2018)

Gentisic acid prevents the transition from pressure overload-induced cardiac hypertrophy to heart failure
por: Sun, Simei, et al.
Publicado: (2019)

The role of androgens in pressure overload myocardial hypertrophy
por: Schafstedde, Marie, et al.
Publicado: (2023)

Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking ELTD1
por: Xiao, Jinfeng, et al.
Publicado: (2012)

The Effects of 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone on the Pressure Overload-Induced Progression of Cardiac Hypertrophy to Cardiac Failure
por: Huang, Jianchun, et al.
Publicado: (2014)

Silencing of circHIPK3 Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction by Sponging miR-185-3p
por: Xu, Xiaohan, et al.
Publicado: (2020)

Suppression of RBFox2 by Multiple MiRNAs in Pressure Overload-Induced Heart Failure
por: Gu, Mingyao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gc9lqk024jmabrh4sie5udkmk9